Jeena Sikho Lifecare Quarterly Results for Trading Insights
In Mar 2026, Jeena Sikho Lifecare (JSLL) reported revenue ₹219 Cr and net profit ₹45 Cr — revenue +56.4% YoY. Browse Jeena Sikho Lifecare annual reports for revenue, profit, balance sheet and cash flow data.
JSLL Quarterly Results — Revenue, Profit & EPS Highlights
Jeena Sikho Lifecare latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore JSLL share price data to track price trends across different timeframes.
- Revenue of ₹219 Cr in Mar 2026 (+14.7% vs Sept 2025, +56.4% vs Mar 2025)
- Net Profit of ₹45 Cr in Mar 2026 (-23.7% vs Sept 2025, +80.0% vs Mar 2025)
- EBITDA of ₹81 Cr in Mar 2026 (-13.8% vs Sept 2025)
- Operating Margin of 36.0% in Mar 2026 (-12.0pp vs Sept 2025)
- Earnings Per Share of ₹3.63 in Mar 2026 (-23.3% vs Sept 2025)
Jeena Sikho Lifecare Quarterly Results — Revenue, EBITDA, Net Profit & EPS
JSLL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 219 | 191 | 140 | 175 | 224 | 14.7% | 56.4% |
| Net Profit (₹ Cr) | 45 | 59 | 25 | 51 | 67 | - | - |
| EBITDA (₹ Cr) | 81 | 94 | 46 | 80 | 103 | - | - |
| EPS (₹) | 3.63 | 4.73 | 2.04 | 4.12 | 5.36 | - | - |
| Operating Margin (%) | 36.0% | 48.0% | 33.0% | 45.0% | 45.0% | - | - |
JSLL Share Price Trend — 1-Year Movement Across Quarterly Results
Jeena Sikho Lifecare 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Jeena Sikho Lifecare stock price NSE.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
JSLL vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Jeena Sikho Lifecare latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹454,122.13 Cr | 1904.8 | 15,018 | 2,710 | +1.0% | +11.8% | 18.0% | 168.6 |
|
Divis Laboratories
Mar 2026 |
₹174,081.02 Cr | 6757.0 | 2,986 | 751 | +4.4% | +11.8% | 25.2% | 238.7 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹161,380.94 Cr | 4768.3 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 414.3 |
|
Cipla
Mar 2026 |
₹117,800.00 Cr | 1458.2 | 6,612 | 543 | -14.3% | -4.0% | 8.2% | 212.3 |
|
Dr Reddys Laborator…
Mar 2026 |
₹114,691.88 Cr | 1374.1 | 7,996 | 221 | -12.5% | -11.5% | 2.8% | 518.5 |
All amounts in ₹ Crores